Sign inGet started

Marks Gilbert Lynn

Insider CIK 1916940 · ANTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ANTX AN2 Therapeutics, Inc. A Award2026-10-122026-10-132,283— $084,156SEC↗
ANTX AN2 Therapeutics, Inc. A Award2026-07-102026-07-102,789— $081,873SEC↗
ANTX AN2 Therapeutics, Inc. A Award2026-04-102026-04-103,775— $079,084SEC↗
ANTX AN2 Therapeutics, Inc. D To issuer deriv2026-03-192026-03-2310,362— $00SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2026-03-192026-03-2323,742— $023,742SEC↗
ANTX AN2 Therapeutics, Inc. D To issuer deriv2026-03-192026-03-2323,742— $00SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2026-03-192026-03-2310,362— $010,362SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2026-03-192026-03-2310,665— $010,665SEC↗
ANTX AN2 Therapeutics, Inc. D To issuer deriv2026-03-192026-03-2310,665— $00SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2026-02-202026-02-2320,400— $020,400SEC↗
ANTX AN2 Therapeutics, Inc. A Award2026-01-122026-01-1411,560— $075,309SEC↗
ANTX AN2 Therapeutics, Inc. A Award2025-10-102025-10-1410,367— $063,749SEC↗
ANTX AN2 Therapeutics, Inc. A Award2025-07-102025-07-1111,875— $053,382SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2025-05-222025-05-2319,111— $019,111SEC↗
ANTX AN2 Therapeutics, Inc. A Award2025-04-102025-04-119,705— $041,507SEC↗
ANTX AN2 Therapeutics, Inc. A Award2024-12-192024-12-238,972— $031,802SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2024-06-192024-06-2164,503— $064,503SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2023-06-072023-06-0923,742— $023,742SEC↗
ANTX AN2 Therapeutics, Inc. A Award deriv2022-05-122022-05-1610,362— $010,362SEC↗